Pfizer Stock Buy Hold or Sell Recommendation

PFE -  USA Stock  

USD 49.92  0.47  0.93%

Considering the 90-day investment horizon and your typical level of risk aversion, our recommendation regarding Pfizer Inc is 'Buy'. Macroaxis provides Pfizer buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Pfizer positions. The advice algorithm takes into account all of Pfizer's available fundamental, technical, and predictive indicators you will find on this site.
  
Refresh
The advice is provided from Pfizer's buy-and-hold perspective. Please check Pfizer Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Pfizer and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Pfizer Inc.

Execute Pfizer Buy or Sell Advice

The Pfizer recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Pfizer Inc. Macroaxis does not own or have any residual interests in Pfizer Inc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Pfizer's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell PfizerBuy Pfizer
Buy

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

UndervaluedDetails

Odds of Distress

LowDetails

Economic Sensitivity

Follows the market closelyDetails

Analyst Consensus

BuyDetails

Reporting Quality (M-Score)

UnavailableDetails
For the selected time horizon Pfizer Inc has a Risk Adjusted Performance of (0.009356), Jensen Alpha of 0.079, Total Risk Alpha of 0.2007 and Treynor Ratio of (0.04149)
Our recommendation tool can be used to complement Pfizer trade recommendations provided by experts. It analyzes the firm's potential to grow against your specific risk preferences and investment horizon. To make sure Pfizer is not overpriced, please check all Pfizer Inc fundamentals, including its cash and equivalents, earnings per share, and the relationship between the revenue and current ratio . Given that Pfizer Inc has a price to earning of 14.26 X, we recommend you to check out Pfizer Inc market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Pfizer Trading Alerts and Improvement Suggestions

About 67.0% of the company shares are owned by institutional investors
Latest headline from www.tipranks.com: Pfizer Biohaven Combine Forces Vying for Valuable Upside - TipRanks

Pfizer Returns Distribution Density

The distribution of Pfizer's historical returns is an attempt to chart the future uncertainty of Pfizer's future price movements. The chart of the probability distribution of Pfizer stock daily returns describes the distribution of returns around its average expected value. We use Pfizer Inc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Pfizer returns is essential to provide solid investment advice for Pfizer stock.
Mean Return-0.02Value At Risk-2.44
Potential Upside3.82Standard Deviation1.84
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Pfizer historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Pfizer Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Pfizer is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pfizer Inc backward and forwards among themselves. Pfizer's institutional investor refers to the entity that pools money to purchase Pfizer's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
California Public Employees Retirement SystemCommon Shares17.9 M924.9 M
Sumitomo Mitsui Trust Holdings IncCommon Shares17.7 M917.1 M
Nordea Investment Management AbCommon Shares12.8 M673.2 M
Dekabank Deutsche GirozentraleCommon Shares8.2 M430.7 M
Robeco Institutional Asset Management BvCommon Shares8.3 M428.6 M
New York State Teachers Retirement SystemCommon Shares6.7 M349.2 M
Envestnet Asset Management IncCommon Shares4.6 M240.5 M
Simplex Trading LlcPut Options4.2 M204.9 M
Simplex Trading LlcCall Options3.1 M158.3 M
Note, although Pfizer's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Pfizer Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Pfizer or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Pfizer stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Pfizer stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
0.08
β
Beta against DOW0.66
σ
Overall volatility
1.82
Ir
Information ratio 0.07

Pfizer Volatility Alert

Pfizer Inc exhibits very low volatility with skewness of 0.59 and kurtosis of -0.27. However, we advise investors to further study Pfizer Inc technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Pfizer's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Pfizer's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Pfizer Implied Volatility

Pfizer's implied volatility exposes the market's sentiment of Pfizer Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Pfizer's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Pfizer stock will not fluctuate a lot when Pfizer's options are near their expiration.

Pfizer Fundamentals Vs Peers

Comparing Pfizer's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Pfizer's direct or indirect competition across all of the common fundamentals between Pfizer and the related equities. This way, we can detect undervalued stocks with similar characteristics as Pfizer or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Pfizer's fundamental indicators could also be used in its relative valuation, which is a method of valuing Pfizer by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Pfizer to competition
FundamentalsPfizerPeer Average
Return On Equity27.75 %(0.31) %
Return On Asset7.78 %(0.14) %
Profit Margin28.68 %(1.27) %
Operating Margin39.38 %(5.51) %
Current Valuation316.52 B16.62 B
Shares Outstanding5.61 B571.82 M
Shares Owned by Insiders0.04 %10.09 %
Shares Owned by Institutions67.43 %39.21 %
Number of Shares Shorted66.01 M4.71 M
Price to Earning14.26 X28.72 X
Price to Book3.70 X9.51 X
Price to Sales4.04 X11.42 X
Revenue69.34 B9.43 B
Gross Profit33.33 B27.38 B
EBITDA27.31 B3.9 B
Net Income19.57 B570.98 M
Cash and Equivalents29.7 B2.7 B
Cash per Share5.29 X5.01 X
Total Debt39.88 B5.32 B
Debt to Equity0.53 %48.70 %
Current Ratio1.38 X2.16 X
Book Value Per Share13.49 X1.93 K
Cash Flow from Operations32.29 B971.22 M
Short Ratio1.50 X4.00 X
Earnings Per Share3.50 X3.12 X
Price to Earnings To Growth0.01 X4.89 X
Number of Employees78.5 K18.84 K
Beta0.62-0.15
Market Capitalization280.19 B19.03 B
Total Asset167.38 B29.47 B
Retained Earnings90.45 B9.33 B
Working Capital14.4 B1.48 B
Current Asset43.8 B9.34 B
   Pfizer exotic insider transaction detected [view details]

About Pfizer Buy or Sell Advice

When is the right time to buy or sell Pfizer Inc? Buying financial instruments such as Pfizer Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Pfizer investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Pfizer in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Communication Thematic Idea Now

Communication
Communication Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Communication theme has 61 constituents.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Communication Theme or any other thematic opportunities.
View All  Next Launch Communication
Please check Pfizer Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.